Low-Dose Sofosbuvir Is Safe and Effective in Treating Chronic Hepatitis C in Patients with Severe Renal Impairment or End-Stage Renal Disease

被引：0
|
作者：
Sunil Taneja
Ajay Duseja
Arka De
Manu Mehta
Raja Ramachandran
Vivek Kumar
Harbir Singh Kohli
Krishan Lal Gupta
Radha Krishan Dhiman
Yogesh Chawla
机构：
[1] Postgraduate Institute of Medical Education and Research,Department of Hepatology
[2] Postgraduate Institute of Medical Education and Research,Department of Nephrology
来源：
Digestive Diseases and Sciences | 2018年 / 63卷
关键词：
Chronic hepatitis C; Sofosbuvir; Daclatasvir; Chronic kidney disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1334 / 1340
页数：6
相关论文
共 50 条
  • [21] Is percutaneous liver biopsy safe in patients with hepatitis C and end-stage renal disease?
    Kallwitz, Eric R.
    Cotler, Scott J.
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2008, 5 (08): : 420 - 421
  • [22] Management of hepatitis C in patients with end-stage renal disease
    Berenguer M.
    Aguilera V.
    Current Hepatitis Reports, 2010, 9 (1) : 38 - 46
  • [23] Assessing and Treating Chronic Pain in Patients with End-Stage Renal Disease
    Coluzzi, Flaminia
    DRUGS, 2018, 78 (14) : 1459 - 1479
  • [24] Assessing and Treating Chronic Pain in Patients with End-Stage Renal Disease
    Flaminia Coluzzi
    Drugs, 2018, 78 : 1459 - 1479
  • [25] The efficacy of low-dose tadalafil in patients undergoing hemodialysis with end-stage renal disease
    Bolat, Mustafa Suat
    Ozer, Ismail
    Cinar, Onder
    Akdeniz, Ekrem
    Asci, Ramazan
    RENAL FAILURE, 2017, 39 (01) : 582 - 587
  • [26] Hepatitis in patients with end-stage renal disease
    Huang, CC
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1997, 12 (9-10) : S236 - S241
  • [27] Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairment
    Sulkowski, Mark
    Telep, Laura E.
    Colombo, Massimo
    Durand, Francois
    Reddy, K. Rajender
    Lawitz, Eric
    Bourliere, Marc
    Cheinquer, Nelson
    Scherbakovsky, Stacey
    Ni, Liyun
    Force, Lindsey
    Ramroth, Heribert
    Gaggar, Anuj
    Chokkalingam, Anand P.
    Sise, Meghan E.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (09) : 1169 - 1178
  • [28] Pharmacokinetics, safety and tolerability of serelaxin in patients with severe renal impairment or end-stage renal disease
    Pang, Y. Yinuo
    Dahlke, M.
    Halabi, A.
    Canadi, J.
    Tsubouchi, C.
    Machineni, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 89 - 89
  • [29] Hepatitis C and management of end-stage renal disease
    Curtis, JJ
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 : 49 - 51
  • [30] Percutaneous liver biopsy in chronic hepatitis C patients with end stage renal disease is safe
    Pawa, S
    Ehrinpreis, MN
    Mutchnick, MG
    Dhar, R
    Siddiqui, FA
    GASTROENTEROLOGY, 2004, 126 (04) : A719 - A719
12345